Lowe, T and Morgan, RJ. Intraperitoneal Chemotherapy of Ovarian Cancer: A Review. Women's Health, 3(4): 433-440 2007

Shibata, S., Chow, W., Frankel, P., Juhasz, A., Koczywas, M., Leong, L., Lim, D., Margolin, K., McNamara, M., Morgan, R., Newman, E., Somlo, G., Twardowski, P., Yen, Y., Synold, T., and Doroshow, J.  A Phase I study of oxaliplatin in combination with gemcitabine: Correlation of clinical outcome with gene expression.  Cancer Chemother Pharmcol 59 (4): 549-557, 2007. 

Morgan, R.J., Synold, T.W., Xi, B., Lim, D., Shibata, S., Margolin, K., Schwarz, R.E., Leong, L., Somlo, G., Twardowski, P., Yen, Y., Chow, W., Tetef, M., Lin, P., Paz, B., Koczywas, M., Wagman, L., Chu, D., Frankel, P., Stalter, S., Doroshow, J.H.  Phase I trial  of intraperitoneal gemcitabine in the treatment of advanced malignancies primarily confined to the peritoneal cavity.  Clinical Cancer Research 13(4): 1232-1237, 2007.

Morgan, R.J., Jr., Synold, T.W., Gandara, D., Muggia, F., Scudder, S., Reed, E., Margolin, K., Raschko, J., Leong, L., Shibata, S., Tetef, M., Vasilev, S., McGonigle, K., Longmate, J., Yen, Y., Chow, W., Somlo, G., Carroll, M. and Doroshow, J.H.  Phase II trial of carboplatin and infusional cyclosporine with alpha-interferon in recurrent ovarian cancer: A California Consortium Trial.  Int. J Gynecol Cancer 2:373-8, 2007.

Morgan, R., Leong, L., Kagan, J., Ball, T., Sanchez, F.  Addressing Underserved Topics: A Continuing Medical Education (CME Challenge).  Proceedings of American Assoc Cancer Education (AACE), 2006 (Abstract and presentation).

Greer, B.E., Koh, W.J., Abu-Rustum, N., Bookman, M.A., Bristow, R.E., Campos, S., Cho, K.R., Copeland, L, Eifel, P., Jaggernauth, W., Jhingran, A., Kapp, D.S., Kavanagh, J., Lipscomb, G.H., Lurain, JR 3rd, Morgan, R.J. Jr., Nag, S., Partridge, E.E,. Powell, C.B., Remmenga, S.W., Reynolds, R.K., Small, W., Jr., Soper, J., Teng, N.  Uterine cancers.  J Natl Compr Canc Netw 4(5): 438-62, 2006.

Morgan, R.J., Jr., Alvarez, R.D., Armstrong, D.K., Chen, L.M., Copeland, L., Fowler, J., Gaffney, D.K., Gershenson, D., Greer, B.E., Johnston, C., Lancaster, J.M., Lele, S., Matulonis, U., Ozols, R.F., Remmenga, S.W., Sabbatini, P., Soper, J., Teng, N.  Ovarian cancer.  Clinical practice guidelines in oncology.  J Natl Compr Canc Netw 4(9): 912-39, 2006.

Openshaw, H., Beamon, K., Synold, T.W., Longmate, J., Slatkin, N.E., Doroshow, J.H., Forman, S., Margolin, K., Morgan, R., Shibata, S., and Somlo, G.  The effect of height on paclitaxel nerve damage.  J. Neurooncology 74: 207-210, 2005.

Lim, D.W., Morgan, R.J., Jr., Akman, S., Margolin, K., Carr, B.I., Leong, L., Odujinrin, O., and Doroshow, J.H.  Phase I trial of menadiol diphosphate (Vitamin K3) in advanced malignancy.  Investigational New Drugs 23: 235-239, 2005.

Morgan, R.J., Jr., Synold, T.W., Gandara, D., Muggia, F., Scudder, S., Reed, E., Margolin, K., Raschko, J., Leong, L., Shibata, S., Tetef, M., Vasilev, S., McGonigle, K., Longmate, J., Yen, Y., Chow, W., Somlo, G., Carroll, M., and Doroshow, J.H.  Phase II trial of carboplatin and infusional cyclosporine in refractory recurrent ovarian cancer.  Cancer Chemother. Pharmacol. 54: 283-289, 2004.

Somlo, G., Frankel, P., Chow, W., Leong, L., Margolin, K., Morgan, Jr., R., Shibata, S., Chu, P., Forman, S., Lim, D., Twardowski, P., Weitzel, J., Alvarnas, J., Kogut, N., Schriber, J., Fermin, E., Damon, L. and Doroshow, J.H.  Prognostic indicators and survival in 120 patients with stage IIIB inflammatory breast carcinoma following dose-intense chemotherapy.  J. Clin. Oncol. 22: 1839-1848, 2004.

Shibata, S.I., Lin, S., Dorohsow, J.H., Pezner, R., Chow, W.A., Leong, L.A., Margolin, K.A., McNamara, M.V., Morgan, R.J., Jr., Raschko, J.W., Somlo, G., Tetef, M.L., Yen, Y., Synold, T.W., Pezner, R., Chu, D., Wagman, L., Vora, N., Carroll, M., Lee, S., and Longmate, J.  Pilot study of intraoperative and external beam radiation therapy combined with continuous infusion 5-fluorouracil in locally advanced gastrointestinal malignancies.  Eur. J. Surg. Oncol.  30: 650-657, 2004.

Morgan, R.J., Jr., Doroshow, J.H., Synold, T., Lim, D., Shibata, S., Margolin, K., Schwarz, R., Leong, L., Somlo, G., Twardowski, P., Yen, Y., Chow, W., Lin, P., Paz, B., Chu, D., Frankel, P., and Stalter, S.:  Phase I trial of intraperitoneal docetaxel in the treatment of advanced malignancies confined to the peritoneal cavity: Dose-limiting toxicity ad pharmacokinetics.  Clin. Cancer Res. 9: 5896-5901, 2003.

Morgan, R.J., Jr., Newman, E., Sowers, L., Scanlon, K., Harrison, J., Akman, S., Leong, L., Margolin, K., Niland, J., Raschko, J., Somlo, G., Carroll, M., Chow, W., Tetef, M., Hamasaki, V., Yen, Y., and Doroshow, J.H.  Phase I Study of cis-diamminedichloroplatinum in combination with azidothymidine in the treatment of patients with advanced malignancies. Cancer Chemother. Pharmacol. 51: 459-464, 2003. 

Morgan, R., Hetrick, V., Leong, L., Grant, M., Pritt, B.  Divergence of perceived educational needs as viewed by physicians vs. health care consumers: Potential impact on continuing medical education (CME) planning.  J Cancer Education (3) 16: 34-35, 2001. (AACE 35th Annual Meeting Program)

Morgan, R.J., Jr., Doroshow, J.H., Leong, L., Schriber, J., Shibata, S., Forman, S., Hamasaki, V., Margolin, K., Somlo, G., Alvarnas, J., McNamara, M., Longmate, J., Raschko, J., Chow, W., Vasilev, S., McGonigle, K., and Yen, Y.  Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer.  Blood Marrow Transplant. 28: 159-183, 2001.

Morgan, R.J., Synold, T.W., Carr, B.I., Doroshow, J.H., Womack, E.P., Shibata, S., Somlo, G., Raschko, J.W., Leong, L., McNamara, M., Chow, W., Tetef, M.L., Margolin, K., Akman, S., and Longmate, J.  Continuous infusion prochlorperazine: Pharmacokinetics, anti-emetic efficacy, and feasibility of high-dose therapy.  Cancer Chemother. Pharmacol. 47: 327-332, 2001.

Morgan, R.J. Jr., Braly, P., Leong, L., Shibata, S., Margolin, K., Somlo, G., McNamara, M., Longmate, J., Schinke, S., Raschko, J., Nagasawa, S., Kogut, N., Najera, L., Johnson, D., and Doroshow, J.H.  Phase II trial of combination intraperitoneal cisplatin and 5-fluorouracil in previously-treated patients with advanced ovarian cancer: Long-term follow-up.   Gynecol. Oncol. 77: 433-438, 2000.

Morgan RJ Jr, Braly P, Cecchi G, Leong L, Shibata S, Margolin K, Somlo G, McNamara M, Longmate J, Schinke S, Raschko J, Nagasawa S, Kogut N, Parker P, Stein A, Cho J, Smith E, Coluzzi P, Najera L, Johnson D, Womack E, Doroshow JH.  Phase II trial of intraperitoneal cisplatin with intravenous doxorubicin and cyclophosphamide in previously untreated patients with advanced ovarian cancer-long-term follow-up. Gynecol Oncol. 1999 Dec;75(3):419-26.

This is a partial list. Full publications list available upon request. Information on this page may be self-reported and is subject to change at any time. Last updated: 07/08.